Creatine (monohydrate)

The most-validated sports supplement in existence and now — post-Forsberg 2024 — a credible cognitive tool for sleep deprivation and high-cognitive-load conditions. Dylan already runs 5-10 g/day for athletic effect (CONFIRMED-IN-USE). Separate optional protocol: a single 20 g pre-emptive dose before predictably sleep-deprived, sparring-heavy, or cognitively demanding days, based on Forsberg 2024 demonstrating brain creatine saturation requires gram-doses higher than muscle saturation. Cheap, daily-safe, no meaningful tolerance, no cycling needed.

Creatine is an endogenous nitrogenous organic acid. The body synthesizes ~1 g/day from arginine + glycine + methionine (S-adenosylmethionine donates the methyl group) primarily in the kidneys and liver via two enzymes — AGAT (arginine:glycine amidinotransferase) and GAMT (guanidinoacetate N-methyltransferase). Another ~1-2 g/day comes from dietary meat/fish in carnivores. Total body pool is ~120 g, ~95% sequestered in skeletal muscle as a mix of free creatine (~40%) and phosphocreatine (~60%). Brain holds ~5% but in functionally critical pools (cerebellum, thalamus, hippocampus, frontal cortex).

The mechanism stack:

1. Phosphocreatine ↔ ATP shuttle (primary). Creatine kinase catalyzes the reversible reaction phosphocreatine + ADP ↔ creatine + ATP. This is the fastest cellular ATP-regeneration system — faster than glycolysis, vastly faster than oxidative phosphorylation. It buffers ATP during sub-second to ~10-second high-demand bursts: maximal lifts, sprints, spikes of neuronal firing. The half-time for phosphocreatine-driven ATP regeneration is on the order of milliseconds; this is why creatine helps maximal-effort short-duration work most.

2. Brain energy buffering (independent pool). The brain has its own creatine kinase isoform (uMtCK + ubiquitous-brain CK) and the SLC6A8 / CRT transporter governs uptake from blood. The brain creatine pool is independently regulated from muscle — muscle saturates at ~3-5 g/day, but brain does not. Brain saturation requires either (a) gram-doses sustained for weeks or (b) acute high doses (~20 g). Forsberg 2024 (Nature Sci Reports) demonstrated +4.4% brain creatine on 31P-MRS after a single 20 g oral dose in 21-32 yo healthy adults. This is the breakthrough that re-frames creatine as a brain-tier compound, not just a muscle compound.

3. Cell-volume osmolyte / cellular swelling. Intracellular creatine raises osmotic pressure, drawing water in. This is what causes the ~1-2 kg weight gain in the first week of use — it's intracellular water in muscle (and to a smaller degree brain), not subcutaneous edema. Cell swelling itself is anabolic-signaling: triggers protein synthesis pathways. Same logic as taurine, but creatine has a much larger osmolyte effect than taurine in muscle.

4. Anti-apoptotic / neuroprotective. Stabilizes mitochondrial membrane potential; reduces mitochondrial-permeability-transition-pore opening; preserves ATP under ischemic/oxidative stress. Animal models of TBI, ischemic stroke, Huntington's, ALS, and Parkinson's show neuroprotection. In humans, the closest evidence is mild concussion-recovery and post-TBI cognitive function trials (small, mostly pediatric). Mechanism is plausible for Dylan's subconcussive-impact context but not directly proven for that use case.

5. Methyl-donor and homocysteine sparing. ~50% of dietary methyl groups (SAM) are consumed by endogenous creatine synthesis (the GAMT step). Supplementing creatine reduces this load, freeing methyl groups for other purposes (DNA methylation, neurotransmitter synthesis, membrane phospholipids). This is the proposed mechanism for vegetarian cognitive responsiveness — vegetarians import zero dietary creatine, run higher methylation demand, and respond more strongly to supplementation. Rae 2003 demonstrated this in a vegetarian RCT.

6. Reduces myostatin / increases satellite cell activation (muscle-specific). Mostly relevant to lean mass + recovery, not brain. Supports the lean-mass effect size in meta-analyses.